Sign Up for Our E-Newsletter

Coming Down the Pipeline: TAS-102

Posted on November 6, 2014

Last week, the FDA granted a fast track designation to TAS-102, a new oral drug for metastatic colorectal cancer patients who have failed at least two previous treatments. We sat down with Patient Advocate Medical Consultant Dr. Laura Porter to learn what’s promising about this upcoming treatment option. Read more

“Don’t be embarrassed, everybody poops!”

Posted on November 5, 2014

people

For National Health Education Week on October 20-24, 2014, we asked you: what is the #1 thing you want the world to know about colon cancer?  You shared some truly inspirational stories and information – thank you! Check out some of the top responses and continue the conversation. Read more

Update: Cologuard Stool DNA Screening Test

Posted on October 31, 2014

Cologuard 1_small

This month, the Centers for Medicare & Medicaid Services (CMS) issued its final National Coverage Decision for Cologuard, making it the first FDA-approved stool DNA test for the detection of colon cancer and precancer covered for Medicare patients throughout the country. This came after the exciting US FDA approval of Cologuard in August. You may have heard some buzz earlier this week about Cologuard’s availability to the public. It turns out some of these facts were incorrect. In order to eliminate any confusion around this new colon cancer screening test, we’re setting the record straight. Check out our updated FAQ to find out what you need to know. Read more

Healthy Hints for a Happy Halloween

Posted on October 29, 2014

halloween fruit2

Can you believe it – Halloween is just a few days away! This time of year is packed with fun fall activities and lots of tasty treats. But while you’re enjoying all the season has to offer, it’s important to keep some nutritional and safety considerations in mind, too. Read more

NEW RESEARCH: Young-Onset Colon Cancer on the Rise

Posted on October 24, 2014

iStock_000020861529XSmall

We continue to expand our efforts in getting young-onset colon cancer on map through our Never Too Young campaign and recent whitepaper because we’re invested in this topic and how it impacts our community. It’s exciting to see that as awareness grows about the increased incidence rates of colon cancer in the under 50 population, more researchers are taking this issue under their wing as an area of exploration. We attended the annual meeting of the American College of Gastroenterology this week and learned about the work investigators at Weill Cornell Medical College in New York are doing on the topic. Read more

css.php